Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma

This study has been terminated.
(There were problems with national reimbursement policies.)
Sponsor:
Information provided by (Responsible Party):
Jung-Hwan Yoon, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01171482
First received: July 22, 2010
Last updated: April 26, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2016
  Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)